Firethorn Wealth Partners LLC Boosts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Firethorn Wealth Partners LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,847 shares of the exchange traded fund’s stock after buying an additional 769 shares during the quarter. Firethorn Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $797,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Hartline Investment Corp increased its stake in SPDR S&P Biotech ETF by 2.0% during the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after acquiring an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC lifted its position in SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after buying an additional 125 shares during the last quarter. Denver Wealth Management Inc. boosted its stake in SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after buying an additional 127 shares during the period. Trust Co. of Vermont increased its position in SPDR S&P Biotech ETF by 4.7% during the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after acquiring an additional 138 shares during the last quarter. Finally, Graypoint LLC raised its stake in shares of SPDR S&P Biotech ETF by 5.6% in the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after acquiring an additional 146 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.6 %

XBI stock opened at $92.46 on Friday. The stock has a market cap of $7.05 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a 50-day moving average price of $93.34 and a 200 day moving average price of $96.88.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.